Condensed Consolidated Statements of Earnings - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Net revenues	$ 6,856	$ 6,837	$ 19,103	$ 19,250
Cost of sales	1,915	2,037	5,367	5,509
Excise taxes on products	1,444	1,545	4,109	4,409
Gross profit	3,497	3,255	9,627	9,332
Marketing, administration and research costs	552	700	1,654	1,959
Asset impairment and exit costs	1	(2)	74	2
Operating income (expense)	2,944	2,557	7,899	7,371
Interest and other debt expense, net	293	159	989	503
Net periodic benefit income, excluding service cost	(24)	(21)	(40)	(37)
Earnings from equity investments	(333)	(189)	(866)	(759)
Impairment of JUUL equity securities	4,500	0	4,500	0
Loss on Cronos-related financial instruments	636	0	1,327	0
Loss on ABI/SABMiller business combination	0	0	0	33
Earnings (losses) before income taxes and equity earnings of subsidiaries	(2,128)	2,608	1,989	7,631
Provision for income taxes	474	664	1,473	1,915
Net earnings (losses)	(2,602)	1,944	516	5,716
Net (earnings) losses attributable to noncontrolling interests	2	(1)	0	(3)
Net earnings (losses) attributable to Altria	$ (2,600)	$ 1,943	$ 516	$ 5,713
Per share data:
Basic and diluted earnings (losses) per share attributable to Altria (in usd per share)	$ (1.39)	$ 1.03	$ 0.27	$ 3.02